03.08.2017 08:00:01

DGAP-News: CompuGroup Medical SE

DGAP-News: CompuGroup Medical SE: Second Quarter Results 2017

DGAP-News: CompuGroup Medical SE / Key word(s): Quarter Results
CompuGroup Medical SE: Second Quarter Results 2017

03.08.2017 / 08:00
The issuer is solely responsible for the content of this announcement.


 

CompuGroup Medical SE - Second Quarter Results 2017

Koblenz - August 3, 2017: CompuGroup Medical SE (CGM) today presented the financial report for the second quarter of 2017. The company, one of the leading global providers of eHealth solutions, achieved revenue of EUR 140 million compared to EUR 136 million in the same period last year. The operating profit (EBITDA) reached EUR 33 million compared to EUR 30 million in the second quarter 2016.

All business segments continue to perform well after the good first quarter start announced in May. For the first six months of 2017 combined, revenue reached EUR 281 million, up from EUR 271 million last year, and EBITDA reached EUR 63 million, up from EUR 61 million in the first half of 2016.

In addition, the first stage testing in the strategically important pilot project for the electronic health card and Telematics Infrastructure in the Northwest region of Germany has now been successfully completed which paves the way for the nationwide roll-out of the Telematics Infrastructure to begin. CGM has already launched the sales campaign for its Telematics Infrastructure connection package to doctors and dentists all over Germany with an early-booker offer valid until the end of August which safeguards a running connection to the Telematics Infrastructure before the end of 2017. The orders received will be installed as soon as the necessary infrastructure components (e.g. connector, card reader, VPN access service, central components) have been certified and approved for productive operation.

Frank Gotthardt, CEO and Chairman of the Board of CompuGroup Medical SE, stated: "We have fought hard this quarter to stay on track both in our running business and in all our preparations for the national roll-out of the Telematics Infrastructure. As for the second point, not only have we been able to accommodate a broad range of new requirements which were added by the authorities all the way up to late June, but in parallel to this also developed a highly efficient installation and deployment process over a shorter time period to compensate for these delays and maintain our 2017 outlook. I am delighted by the initial reception by doctors and dentist to the offer we launched in July and I look forward to connect a substantial number of practices to the Telematics Infrastructure by the end of this year. These early adopters are the true pioneers of German healthcare and their commitment makes a strong contribution to solve the enormous challenge of the industry to serve their whole customer base in an ambitious time frame and to keep all customers safe and compliant to the eHealth law while at the same time securing doctors and dentists the maximum cost reimbursement under their financing agreements."

CGM reaffirms the full year 2017 guidance presented in the 2016 Annual Report. Group revenue is expected to be in the range of EUR 600 million and EUR 630 million and operating profit (EBITDA) between EUR 138 million and EUR 150 million.

Conference Call for Journalists, Investors and Analysts:
The management board of CompuGroup Medical SE will go through the results at a conference for analysts and investors today at 15:00 hours CEST.

You can participate in this conference call by dialing one of the following phone numbers:

+49 (0) 69 2 10 86 97 03 (Germany)
+44 (0) 16 16 01 89 02 (UK)
+1 (0) 21 33 75 04 79 (USA)
Participant code: 89 27 94 87

A presentation will be available for download on www.cgm.com/investor-relations prior to the conference call and can also be viewed live at: www.cgm.com/onlinepresentation.

About CompuGroup Medical SE
CompuGroup Medical is one of the leading eHealth companies in the world. With a revenue base of more than EUR 550 million, its software products are designed to support all medical and organizational activities in doctors' offices, pharmacies, laboratories and hospitals. Its information services for all parties involved in the healthcare system and its web-based personal health records contribute towards safer and more efficient healthcare. CompuGroup Medical's services are based on a unique customer base of approximately 400,000 doctors, dentists, pharmacists and other service providers in inpatient and outpatient facilities. With locations in 20 countries and products in more than 46 countries worldwide, CompuGroup Medical is the eHealth company with one of the highest coverage among eHealth service providers. Approximately 4,300 highly qualified employees support customers with innovative solutions for the steadily growing demands of the healthcare system.

Editorial Staff Contact Information:

CompuGroup Medical SE
Oliver Bruzek

Chief Communication Officer
T +49 (0) 261 8000-6100
F +49 (0) 261 8000-3100
E-Mail: press@cgm.com



03.08.2017 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de


Language: English
Company: CompuGroup Medical SE
Maria Trost 21
56070 Koblenz
Germany
Phone: +49 (0)261 8000 6200
Fax: +49 (0)261 8000 3200
E-mail: investor@cgm.com
Internet: www.cgm.com
ISIN: DE0005437305
WKN: 543730
Indices: TecDAX
Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange

 
End of News DGAP News Service

598373  03.08.2017 

fncls.ssp?fn=show_t_gif&application_id=598373&application_name=news&site_id=smarthouse

Analysen zu CompuGroup Medical SEmehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!